These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 33780087)

  • 21. Viral expression of ALS-linked ubiquilin-2 mutants causes inclusion pathology and behavioral deficits in mice.
    Ceballos-Diaz C; Rosario AM; Park HJ; Chakrabarty P; Sacino A; Cruz PE; Siemienski Z; Lara N; Moran C; Ravelo N; Golde TE; McFarland NR
    Mol Neurodegener; 2015 Jul; 10():25. PubMed ID: 26152284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutant UBQLN2
    Chen T; Huang B; Shi X; Gao L; Huang C
    Acta Neuropathol Commun; 2018 Nov; 6(1):122. PubMed ID: 30409191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal transcriptomic analysis of altered pathways in a CHMP2B
    Waegaert R; Dirrig-Grosch S; Parisot F; Keime C; Henriques A; Loeffler JP; René F
    Neurobiol Dis; 2020 Mar; 136():104710. PubMed ID: 31837425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation-dependent aggregation and toxicity in a Drosophila model for UBQLN2-associated ALS.
    Kim SH; Stiles SG; Feichtmeier JM; Ramesh N; Zhan L; Scalf MA; Smith LM; Pandey UB; Tibbetts RS
    Hum Mol Genet; 2018 Jan; 27(2):322-337. PubMed ID: 29161404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ubiquilin 2 mutations in Italian patients with amyotrophic lateral sclerosis and frontotemporal dementia.
    Gellera C; Tiloca C; Del Bo R; Corrado L; Pensato V; Agostini J; Cereda C; Ratti A; Castellotti B; Corti S; Bagarotti A; Cagnin A; Milani P; Gabelli C; Riboldi G; Mazzini L; Sorarù G; D'Alfonso S; Taroni F; Comi GP; Ticozzi N; Silani V;
    J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):183-7. PubMed ID: 23138764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel UBQLN2 mutations linked to amyotrophic lateral sclerosis and atypical hereditary spastic paraplegia phenotype through defective HSP70-mediated proteolysis.
    Teyssou E; Chartier L; Amador MD; Lam R; Lautrette G; Nicol M; Machat S; Da Barroca S; Moigneu C; Mairey M; Larmonier T; Saker S; Dussert C; Forlani S; Fontaine B; Seilhean D; Bohl D; Boillée S; Meininger V; Couratier P; Salachas F; Stevanin G; Millecamps S
    Neurobiol Aging; 2017 Oct; 58():239.e11-239.e20. PubMed ID: 28716533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuronal Expression of UBQLN2
    Picher-Martel V; Renaud L; Bareil C; Julien JP
    Mol Neurobiol; 2019 Jul; 56(7):4680-4696. PubMed ID: 30377984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. UBQLN proteins in health and disease with a focus on UBQLN2 in ALS/FTD.
    Lin BC; Higgins NR; Phung TH; Monteiro MJ
    FEBS J; 2022 Oct; 289(20):6132-6153. PubMed ID: 34273246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Making connections: pathology and genetics link amyotrophic lateral sclerosis with frontotemporal lobe dementia.
    Fecto F; Siddique T
    J Mol Neurosci; 2011 Nov; 45(3):663-75. PubMed ID: 21901496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hippocampal aggregation signatures of pathogenic UBQLN2 in amyotrophic lateral sclerosis and frontotemporal dementia.
    Thumbadoo KM; Dieriks BV; Murray HC; Swanson MEV; Yoo JH; Mehrabi NF; Turner C; Dragunow M; Faull RLM; Curtis MA; Siddique T; Shaw CE; Newell KL; Henden L; Williams KL; Nicholson GA; Scotter EL
    Brain; 2024 May; ():. PubMed ID: 38703371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia.
    Deng HX; Chen W; Hong ST; Boycott KM; Gorrie GH; Siddique N; Yang Y; Fecto F; Shi Y; Zhai H; Jiang H; Hirano M; Rampersaud E; Jansen GH; Donkervoort S; Bigio EH; Brooks BR; Ajroud K; Sufit RL; Haines JL; Mugnaini E; Pericak-Vance MA; Siddique T
    Nature; 2011 Aug; 477(7363):211-5. PubMed ID: 21857683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. UBQLN2 and HSP70 participate in Parkin-mediated mitophagy by facilitating outer mitochondrial membrane rupture.
    Ma Q; Xin J; Peng Q; Li N; Sun S; Hou H; Ma G; Wang N; Zhang L; Tam KY; Dussmann H; Prehn JH; Wang H; Ying Z
    EMBO Rep; 2023 Sep; 24(9):e55859. PubMed ID: 37501540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disturbance of proteasomal and autophagic protein degradation pathways by amyotrophic lateral sclerosis-linked mutations in ubiquilin 2.
    Osaka M; Ito D; Suzuki N
    Biochem Biophys Res Commun; 2016 Apr; 472(2):324-31. PubMed ID: 26944018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutant UBQLN2 promotes toxicity by modulating intrinsic self-assembly.
    Sharkey LM; Safren N; Pithadia AS; Gerson JE; Dulchavsky M; Fischer S; Patel R; Lantis G; Ashraf N; Kim JH; Meliki A; Minakawa EN; Barmada SJ; Ivanova MI; Paulson HL
    Proc Natl Acad Sci U S A; 2018 Oct; 115(44):E10495-E10504. PubMed ID: 30333186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of ALS/FTD-linked mutant CCNF in zebrafish leads to increased cell death in the spinal cord and an aberrant motor phenotype.
    Hogan AL; Don EK; Rayner SL; Lee A; Laird AS; Watchon M; Winnick C; Tarr IS; Morsch M; Fifita JA; Gwee SSL; Formella I; Hortle E; Yuan KC; Molloy MP; Williams KL; Nicholson GA; Chung RS; Blair IP; Cole NJ
    Hum Mol Genet; 2017 Jul; 26(14):2616-2626. PubMed ID: 28444311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wild-type and pathogenic forms of ubiquilin 2 differentially modulate components of the autophagy-lysosome pathways.
    Idera A; Sharkey LM; Kurauchi Y; Kadoyama K; Paulson HL; Katsuki H; Seki T
    J Pharmacol Sci; 2023 Jul; 152(3):182-192. PubMed ID: 37257946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disulfide cross-linked multimers of TDP-43 and spinal motoneuron loss in a TDP-43
    Bargsted L; Medinas DB; Martínez Traub F; Rozas P; Muñoz N; Nassif M; Jerez C; Catenaccio A; Court FA; Hetz C; Matus S
    Sci Rep; 2017 Oct; 7(1):14266. PubMed ID: 29079747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ALS-Linked Mutations Affect UBQLN2 Oligomerization and Phase Separation in a Position- and Amino Acid-Dependent Manner.
    Dao TP; Martyniak B; Canning AJ; Lei Y; Colicino EG; Cosgrove MS; Hehnly H; Castañeda CA
    Structure; 2019 Jun; 27(6):937-951.e5. PubMed ID: 30982635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deletion of Tbk1 disrupts autophagy and reproduces behavioral and locomotor symptoms of FTD-ALS in mice.
    Duan W; Guo M; Yi L; Zhang J; Bi Y; Liu Y; Li Y; Li Z; Ma Y; Zhang G; Liu Y; Song X; Li C
    Aging (Albany NY); 2019 Apr; 11(8):2457-2476. PubMed ID: 31039129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human Ubiquilin 2 and TDP-43 copathology drives neurodegeneration in transgenic Caenorhabditis elegans.
    Saxton AD; Kraemer BC
    G3 (Bethesda); 2021 Aug; 11(8):. PubMed ID: 33963840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.